Silence Therapeutics PLC
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -724.0% | – | -721.0% | – | – | – | |
| – | -45.2% | +70.3% | +39.7% | -7.9% | +20.8% | +2.9% | +16.2% | +3.4% | -16.4% | -4.8% | +17.1% | |
| – | -31.1% | -38.9% | +34.3% | +6.7% | -14.2% | +652.6% | +165.1% | +8.9% | +2.9% | -20.2% | -22.4% | |
| – | – | – | – | – | -176.1% | – | -7.2% | -59.5% | – | – | – | |
| – | – | – | – | -135.1% | – | -11.5% | +181.0% | -137.0% | – | – | – | |
| – | +151.5% | -36.8% | -67.8% | +8.7% | -95.2% | +5,611.1% | +250.3% | -69.7% | -91.7% | +274.7% | -67.4% | |
| – | – | -208.1% | – | -137.1% | +210.9% | – | +21.7% | -275.1% | – | -206.8% | +173.4% | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | +0.0% | +0.0% | +0.0% | -47.5% | -10.0% | +16.7% | – | – | |
| – | +261.1% | -100.3% | – | +610.4% | +1,446.3% | +192.6% | +168.7% | +26.9% | -52.2% | +351.4% | -100.0% | |
| – | +3,524.6% | -136.8% | – | -669.3% | – | – | +346.4% | -153.2% | – | – | -362.1% | |
| – | – | – | – | – | – | -757.2% | – | -879.8% | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.